184 related articles for article (PubMed ID: 1465994)
1. T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma.
Przepiorka D; Giralt S; Huh YO; Andreeff M; Luna M; Reading C; Thomas M; Champlin RE
Transplant Proc; 1992 Dec; 24(6):2906-7. PubMed ID: 1465994
[No Abstract] [Full Text] [Related]
2. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
[TBL] [Abstract][Full Text] [Related]
3. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
Gale RP; Horowitz MM
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
Mrsić M; Nemet D; Labar B; Bogdanić V; Radman I; Zupancić-Salek S; Kovacević-Metelko J; Aurer I; Maravić N
Transplant Proc; 1993 Feb; 25(1 Pt 2):1268-70. PubMed ID: 8442109
[No Abstract] [Full Text] [Related]
5. Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow.
Soiffer RJ; Mauch P; Tarbell NJ; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Murrey CI; Coral F; Bosserman L
Bone Marrow Transplant; 1991 Jan; 7(1):23-33. PubMed ID: 2043874
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
[TBL] [Abstract][Full Text] [Related]
7. Autologous marrow transplantation in acute lymphoblastic leukemia: control of residual disease with mafosfamide and induction of syngeneic GVHD with cyclosporin. The Italian Mafosfamide Study Group.
Rizzoli V; Carella AM; Carlo-Stella C; Mangoni L
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():76-8. PubMed ID: 2202474
[No Abstract] [Full Text] [Related]
8. Lymphocyte reconstitution after allogeneic bone marrow transplantation in a previously thymectomized patient--no evidence of extrathymic T-cell maturation.
Giebel S; Dziaczkowska J; Wysoczanska B; Wojnar J; Krawczyk-Kulis M; Lange A; Holowiecki J
Bone Marrow Transplant; 2007 Oct; 40(7):705-6. PubMed ID: 17680024
[No Abstract] [Full Text] [Related]
9. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
[TBL] [Abstract][Full Text] [Related]
11. [Allogeneic bone marrow transplantation in acute and chronic myeloid leukemia: role of conditioning and of graft-versus-host disease in the long-term maintenance of remission].
Bacigalupo A; Frassoni F; Van Lint MT; Occhini D; Gualandi F; Lamparelli T; Vitale V; Scarpati D; Clavio M; Marmont AM
Haematologica; 1989 Oct; 74(5 Suppl):425-32. PubMed ID: 2512226
[No Abstract] [Full Text] [Related]
12. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
[TBL] [Abstract][Full Text] [Related]
13. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
14. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation.
Champlin R
Hematol Oncol Clin North Am; 1990 Jun; 4(3):687-98. PubMed ID: 2193019
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens.
Woods WG; Ramsay NK; Weisdorf DJ; Haake R; Vallera DA; Kim TH; Lasky L; Nesbit ME; Bostrom B; Uckun F
Bone Marrow Transplant; 1990 Jul; 6(1):9-16. PubMed ID: 2202462
[TBL] [Abstract][Full Text] [Related]
16. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
17. [The effect of HGF on graft-versus-host disease and graft-versus-leukemia after allogeneic bone marrow transplantation in acute lymphoblastic leukemia mice].
Xia YJ; Gao QP; Wan CC; Cheng FJ; Liu ZX; Guo RC
Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):404-7. PubMed ID: 16251021
[TBL] [Abstract][Full Text] [Related]
18. Initial experiences in allogeneic bone marrow transplantation for leukaemias: report of National Institute of Haematology and Blood Transfusion (Hungary).
Poros A; Petrányi J; Harsányi V; Mód A; Bernyäk J; Hollán Z
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):409-11. PubMed ID: 2480282
[No Abstract] [Full Text] [Related]
19. Bone marrow transplantation with T-cell depleted allografts for the treatment of severe beta thalassemia major.
Or R; Naparstek E; Aker M; Cividalli G; Engelhard D; Brautbar C; Weshler Z; Weiss L; Mumcuoglu M; Rachmilewitz EA
Prog Clin Biol Res; 1989; 309():217-22. PubMed ID: 2675089
[No Abstract] [Full Text] [Related]
20. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
Soderling CC; Song CW; Blazar BR; Vallera DA
J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
